Evidence map›Paper›PMID 40919023›Full record

ArticleBMJ public health2025

Trends in the illicit tobacco market in New Zealand: a consumption gap analysis.

Pyi Pyi Phyo, Christopher Bullen

Abstract read
In one paragraph

Article in BMJ public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Pyi Pyi PhyoSchool of Population Health, The University of Auckland, Auckland, New Zealand.ORCID https://orcid.org/0009-0005-4425-9449
Christopher BullenSchool of Population Health, The University of Auckland, Auckland, New Zealand.ORCID https://orcid.org/0000-0001-6807-2930

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Illicit tobacco poses a significant challenge to public health efforts. New Zealand (NZ) stands out for its stringent tobacco control policies, but there are concerns that the size of the illicit market could grow. Estimating the extent of the illicit tobacco trade in NZ remains challenging due to the diverse methodologies used by various stakeholders over different years. Methods: We did annual consumption gap analyses (CGA) from 2012 to 2023 by calculating the discrepancy between estimated cigarette smoking (factory-made cigarettes and roll-your-own cigarettes) and legal sales to examine trends in the illicit tobacco trade in NZ. Results: The proportion of illicit tobacco in the NZ market fluctuated between 2012 and 2023. The negative test statistic of Kendall's tau indicates a slightly downward trend, but the trend is weak and statistically insignificant. The negative percentage may reflect under-reporting or the absence of hidden populations' consumption estimates, or the overestimation of legal sales. Our analyses adjust for under-reporting of smoking by using an uplift factor of 1.23 and adopt a 'worst-case scenario' by using the upper limit of the 95% CI around the point estimate for the proportion of daily smokers. Conclusion: CGA is a useful tool for estimating the illicit tobacco trade, but it depends on accurate and valid estimates of consumption, under-reporting and reporting of legal tobacco supply. It is most useful to estimate the trend rather than the absolute amount of illicit tobacco. In NZ, the estimated proportion of illicit tobacco fluctuated between 2012 and 2023, supported by the statistically insignificant Mann-Kendall test. Reducing demand for smoking, alongside more vigorous border scrutiny and enforcement, is the most effective strategy for tackling the illicit trade. NZ's Smokefree aspirations to see prevalence drop to 5% or lower in the next few years may, therefore, significantly reduce the size of the illicit tobacco market.

Indexed as

Community HealthPublic Healthtrends

Identifiers

PMID40919023
PMCPMC12410603

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.